AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT05004987 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Escitalopram Oxalate
Description: The daily dose of ESC/PBO will be 10 mg for the first 2 weeks, then increase to 20 mg as tolerated, with an option to reduce back to 10 mg if necessary.
Study NCT05004987 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Daily dose of placebo will mimic that of ESC.
Study NCT06717685 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Adenosine
Description: Adenosine is a medication belonging to class V antidysrhythmics, used to treat a type of irregular heart rhythm disorder known as paroxysmal supraventricular tachycardia (PSVT)
Study NCT06717685 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Verapamil Injection
Description: Verapamil is in a class of medications called calcium-channel blockers. It works by relaxing the blood vessels so the heart does not have to pump as hard. It also increases the supply of blood and oxygen to the heart and slows electrical activity in the heart to control the heart rate.
Study NCT06733246 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Aspiration 0
Description: Ceretrieve is a neuro-thrombectomy aspiration catheter deigned for clot removal in AIS patients.
Study NCT06732388 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Biopsy
Description: Undergo tissue biopsy
Study NCT06732388 — intervention group
Intervention type: PROCEDURE
Group type: PLACEBO_COMPARATOR
Intervention: Biopsy
Description: Undergo tissue biopsy
Study NCT05353374 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Sodium Fusidate 2 % Topical Ointment
Description: Sodium fusidate 2% topical ointment was applied twice daily on the wound after cauterization for 14 days.
Study NCT05353374 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Petrolatum ointment
Description: Petrolatum ointment was applied twice daily on the wound after cauterization for 14 days.
Study NCT05368142 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Nocardia rubra Cell Wall Skeleton
Description: Nocardia rubra cell wall skeleton for external application
Study NCT06732388 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Biospecimen Collection
Description: Undergo blood sample collection
Study NCT05368142 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Silver ions dressing
Description: Silver ions dressing for external application
Study NCT06732388 — intervention group
Intervention type: PROCEDURE
Group type: PLACEBO_COMPARATOR
Intervention: Biospecimen Collection
Description: Undergo blood sample collection
Study NCT06732388 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Endoscopic Procedure
Description: Undergo endoscopy
Study NCT04984109 — intervention group
Intervention type: PROCEDURE
Group type: SHAM_COMPARATOR
Intervention: Sham PENG block
Description: The regional block will be performed with the patient in the supine position in operative area with adequate groin exposure. The probe will first be placed at the anterior superior iliac spine in transverse plane, and then will be moved caudally to identify anterior inferior iliac spine (AIIS). The probe will be then rotated to align the AIIS and iliopubic eminence (IPE). This will reveal the iliopsoas tendon and muscle together with femoral vessels superficially. A 22-G 100-mm echogenic needle will be inserted in-plane from lateral to medial, and the tip will be kept at the midpoint of AIIS and IPE deep to psoas tendon. After lifting of psoas tendon by hydrolocation, the patients in PENG group will receive 1 mL of normal saline.
Study NCT04984109 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Real PENG block
Description: The regional block will be performed with the patient in the supine position in operative area with adequate groin exposure. The probe will first be placed at the anterior superior iliac spine in transverse plane, and then will be moved caudally to identify anterior inferior iliac spine (AIIS). The probe will be then rotated to align the AIIS and iliopubic eminence (IPE). This will reveal the iliopsoas tendon and muscle together with femoral vessels superficially. A 22-G 100-mm echogenic needle will be inserted in-plane from lateral to medial, and the tip will be kept at the midpoint of AIIS and IPE deep to psoas tendon. After lifting of psoas tendon by hydrolocation, the patients in PENG group will receive 20 ml of (0.25%) bupivacaine with 0.2 mg/mL dexamethasone that will be injected in 5 ml aliquots after negative aspiration.
Study NCT06732388 — intervention group
Intervention type: PROCEDURE
Group type: PLACEBO_COMPARATOR
Intervention: Endoscopic Procedure
Description: Undergo endoscopy
Study NCT06732388 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Itraconazole
Description: Given PO
Study NCT06732388 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo Administration
Description: Given PO
Study NCT06732388 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Questionnaire Administration
Description: Ancillary studies
Study NCT06732388 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Questionnaire Administration
Description: Ancillary studies
Study NCT06732388 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Radiofrequency Ablation
Description: Undergo radiofrequency ablation
Study NCT06732388 — intervention group
Intervention type: PROCEDURE
Group type: PLACEBO_COMPARATOR
Intervention: Radiofrequency Ablation
Description: Undergo radiofrequency ablation
Study NCT06454032 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Fitness walking
Description: Fitness walking for 12 weeks.
Study NCT06454032 — intervention group
Intervention type: BEHAVIORAL
Group type: SHAM_COMPARATOR
Intervention: Maintained lifestyle
Description: Maintained their normal lifestyle, without exercise intervention.
Study NCT06182306 — intervention group
Intervention type: PROCEDURE
Intervention: Biopsy
Description: Patients undergo a biopsy from a lesion, and give 40ml of blood
Study NCT04896398 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: ESWT
Description: In the study group, a total of 5 sessions of focused ESWT (1000 shock, 1.6 bar, 5 Hz) will be applied to the affected wrist within 2 weeks.
Study NCT06406647 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: retrocalvicular block
Description: retrocalvicular block in upper limb orthopedic Surgey
Study NCT06347497 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Zonisamide 50 MG
Description: The arm will include 300 migraine patients diagnosed according to ICHD3-beta criteria. We will assess The change in migraine days per 28 days, the number of migraine days after three months of treatment, and the percentage of patients who achieved ≥ 50% reduction in the monthly headache days frequency compared to the baseline frequency (14). HIT-6 score reduction in each group after three months of treatment. The safety of zonisamide was evaluated by monitoring and documenting treatment-emergent adverse events (TEAE) in patients through regular follow-up procedures for three months.
Study NCT06279546 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Detection of structures
Description: Pre-recorded videos, cropped according to the different windows (mediastinal, gastric, duodenal) will be analyzed by the AIWorks-EUS model and endoscopists on different times for recognition of the different normal anatomical structures.
Study NCT06065917 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Measurement of the total small bowel length using CT scan and MRI with 3D reconstruction and AI tool
Description: The intervention consists in performing CT and MR imaging with small bowel length measurement before bariatric/metabolic surgery in obese patients. Then, during surgery the patients will undergo laparoscopic stretched small bowel measurement as the reference gold standard method to measure the small bowel length. The imaging of the training cohort will be used to trained an AI to set up an automatic method of small bowel length measurement via the analysis of CT and MRI imaging.
Study NCT04720924 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Computer-aided Real-time Automatic Quality-control System
Description: EGD automatic quality-control system(AQCS),developed based on deep convolutional neural network (DCNN) models,could facilitate real-time detection of upper gastrointestinal lesions, assess inspection completeness and mucosal visibility, and calculate time of EGD procedure.
Study NCT05540925 — intervention group
Intervention type: PROCEDURE
Intervention: Liver resection
Description: All patients underwent curative-intent resection for early-stage HCC (a solitary tumor nodule≤5 cm, or multiple nodules≤3, each≤3 cm).~We did not take any other intervention. We retrospectively analyzed the prognostic performance of patients with wide (≥1cm) or narrow (\<1cm) resection margin in different groups.
Study NCT05347264 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: gun massager
Description: 15 to 20 minutes along with hot pack.
Study NCT05347264 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: transverse friction massage
Description: 15 to 20 minutes along with hot pack.
Study NCT05087082 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Virtual Hospital at Home - Home admission of epidemic patients
Description: Admitting COVID-19 patients at home
Study NCT04167033 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Hormone replacement therapy:effect on ventricular repolarization
Description: Hormone replacement therapy and QTc measurement
Study NCT04167033 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: OTHER
Intervention: ECG
Description: QTc measurement
Study NCT06347497 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Topiramate 50 MG
Description: The arm will include 300 migraine patients diagnosed according to ICHD3-beta criteria. We will assess The change in migraine days per 28 days, the number of migraine days after three months of treatment, and the percentage of patients who achieved ≥ 50% reduction in the monthly headache days frequency compared to the baseline frequency (14). HIT-6 score reduction in each group after three months of treatment. The safety of topiramate was evaluated by monitoring and documenting treatment-emergent adverse events (TEAE) in patients through regular follow-up procedures for three months.
Study NCT05427565 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: caffeine
Description: The investigators will ask participant to only intake 200 mg of caffeine one hour before the experiment (no other caffeine intake since the wake-up) or avoid caffeine intake at all before the experiment
Study NCT05427565 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Experimental time
Description: The investigators will ask participant to attend the experiment in the morning or afternoon
Study NCT05306041 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Inavolisib
Description: daily application of 9 mg (may be decreased to 6 mg and to 3 mg)
Study NCT05306041 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: PHESGO
Description: fixed-dose combination of pertuzumab and trastuzumab with hyaluronidase s.c. (PH-FDC SC) q3w beginning on day 1 of cycle 1 for 6 cycles (18 weeks)
Study NCT05306041 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: PHESGO
Description: fixed-dose combination of pertuzumab and trastuzumab with hyaluronidase s.c. (PH-FDC SC) q3w beginning on day 1 of cycle 1 for 6 cycles (18 weeks)
Study NCT05306041 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Endocrine therapy
Description: Endocrine therapy per physician´s choice with either tamoxifen 20mg or an aromatase inhibitor +/- GnRH analogue for premenopausal women and men
Study NCT05306041 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: Endocrine therapy
Description: Endocrine therapy per physician´s choice with either tamoxifen 20mg or an aromatase inhibitor +/- GnRH analogue for premenopausal women and men
Study NCT06363370 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Human interferon α1b Inhalation Solution
Description: Participants will receive Human interferon α1b Inhalation Solution
Study NCT06363370 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Inhalation Solution Placebo
Description: Participants will receive Inhalation Solution Placebo
Study NCT04869774 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: How2Trak mobile application
Description: Patients will undergo virtual monitoring of their incision and symptoms using the How2Trak application(app). Using the app, patients will be asked to answer a series of questions and photograph their surgical incision on post-operative day 3, 5, 7, 10, 20, and 30. Patient responses and photographs entered into the app will be reviewed within 72 hours by a trained Nurse Specialized in Wound, Ostomy and Continence. If a concern is identified the nurse will contact the patient to arrange a virtual visit using the how2trak app or notify the surgeon team (including colorectal surgeons and physician residents) in accordance with clinical discretion.
Study NCT06455293 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Psilocybin
Description: Single dose of psilocybin ranging from low (microdose) to high delivered orally with psychological support and monitoring
Study NCT06068985 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: PHESGO
Description: Subcutaneous formulation with pertuzumab and trastuzumab.
Study NCT05918601 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Health-risk behaviors
Description: Participants will be asked about the priority they place on engagement in health-related lifestyles, such as quitting drugs, alcohol, smoking or exercising regularly.
Study NCT05918601 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Theory of planned behavior, Self-determination theory
Description: The participants will be asked to quit drugs immediately or progressively with the ultimate goal of quitting drugs completely.
Study NCT05918601 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Theory of planned behavior, Self-determination theory
Description: The participants will be asked to quit drugs immediately or progressively with the ultimate goal of quitting drugs completely.
Study NCT05918601 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Assist them to adhere to their schedule of quitting drugs throughout the study period
Description: The participants will receive instant messaging via WeChat or WhatsApp from peer supporters to assist them to adhere to their schedule of quitting drugs throughout the study period.
Study NCT05918601 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Assist them to adhere to their schedule of quitting drugs throughout the study period
Description: The participants will receive instant messaging via WeChat or WhatsApp from peer supporters to assist them to adhere to their schedule of quitting drugs throughout the study period.
Study NCT05918601 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Assist them to adhere to their schedule of desirable health-related lifestyles/quitting drugs throughout the study period
Description: The participants will receive instant messaging via WeChat or WhatsApp from peer supporters to assist them to adhere to their schedule of desirable health-related lifestyles/quitting drugs throughout the study period.
Study NCT05918601 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: (AWARD) model
Description: Participants receive a brief intervention using the Ask, Warn, Advise, Refer and Do-it-Again (AWARD) model
Study NCT05918601 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: (AWARD) model
Description: Participants receive a brief intervention using the Ask, Warn, Advise, Refer and Do-it-Again (AWARD) model
Study NCT05918601 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Receive four independent 1-minute videos
Description: The participants will receive four independent 1-minute videos which focus on the health risks associated with abusing drugs and the benefits of quitting drugs.
Study NCT05918601 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Receive four independent 1-minute videos
Description: The participants will receive four independent 1-minute videos which focus on the health risks associated with abusing drugs and the benefits of quitting drugs.
Study NCT06128928 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: REDES
Description: Training on motivational interviewing (MI) led by community health workers on how to use MI to address vaccine hesitancy using a guiding approach, open-ended questions, affirmations, reflections, and summaries.
Study NCT06128928 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Control
Description: Brief CHW-led training about the safety and efficacy of the COVID-19 vaccine. Participants will have the opportunity to ask clarifying questions from the CHWs during the training.
Study NCT06363773 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: Stereotactic Radiotherapy
Description: Patients will perform stereotactic radiotherapy with 3 sessions (8 Gy) during 20 minutes each and with 72 hours in-between.~Patients enrolled in the study would not have received this stereotactic radiotherapy outside the study, that is why this procedure is additional (compared to Standard of care) and considered as burdensome (as this is radiation). Before performing the stereotactic radiotherapy, patients will do a radiotherapy CT scanner (no injected) in order to prepare precisely the radiotherapy (treatment plan).
Study NCT06558383 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: augmented posterior oblique sling activation
Description: activation of posterior oblique sling for 18 sessions, three sessions per week for six weeks
Study NCT06558383 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: selected physical therapy program
Description: selected physical therapy program for 18 sessions, three sessions per week for six weeks in form hot packs, soft tissue techniques, mobilization and manipulation of lumbar spine, and neurodynamics and stabilization exercises
Study NCT05498844 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Medical Nutrition Therapy (counselling)
Description: Participants will receive nutrition counseling to enhance adherence to the principles of the Mediterranean diet and support the achievement of adequate levels of lipid control, blood pressure and weight.
Study NCT05498844 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Medical Nutrition Therapy (counselling)
Description: Participants will receive nutrition counseling to enhance adherence to the principles of the Mediterranean diet and support the achievement of adequate levels of lipid control, blood pressure and weight.
Study NCT05010252 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Cycled light Experimental
Description: The preliminary plan of this study is to carry out empirical evidence and expert advice to confirm precise lighting and develop care intervention strategies for preterm infants based on evidence. It is planned to be in the Neonatal Intermediate Care Nursery, National Taiwan University Children's Hospital, and the subjects are premature babies born 32 weeks old. Divided into two groups of light intervention group and control group, longitudinal tracking intervention effect and six-weeks and three-months delay effect.
Study NCT05543291 — intervention group
Intervention type: BEHAVIORAL
Intervention: renal function
Description: levels of eGFR
Study NCT06119984 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Community mobilization
Description: The intervention focused on creating awareness, challenging social norms, and promoting actions against violence. To achieve these, the following activities were undertaken: introductory meetings, selection and training of model couples, structured workshops and small group meetings.
Study NCT05307770 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Immediate Release Melatonin
Description: 5 mg orally every night at 9 pm for 4 weeks
Study NCT05307770 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Extended Release Melatonin
Description: 5 mg orally every night at 9 pm for 4 weeks
Study NCT06223412 — intervention group
Intervention type: BEHAVIORAL
Group type: PLACEBO_COMPARATOR
Intervention: video-based climate change program
Description: The participants in this group received a series of short videos, ranging between 30- 45 minutes/ each video revolved around five core themes including The road start to green planet, The ripple effect climate change on Health, Climate Change Literacy, Strengthen resilience to overcome climate related- psychological impacts, and Sustaining phase: closing session.
Study NCT06223412 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: video-based climate change program
Description: The participants in this group received a series of short videos, ranging between 30- 45 minutes/ each video revolved around five core themes including The road start to green planet, The ripple effect climate change on Health, Climate Change Literacy, Strengthen resilience to overcome climate related- psychological impacts, and Sustaining phase: closing session.
Study NCT06528483 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Sacituzumab Govitecan + Zimberelimab
Description: Sacituzumab Govitecan 7.5 mg/kg IV for 3 cycles Zimberelimab 360 mg IV for 16 cycles~Patients will be treated with Sacituzumab Govitecan 1,8q21 plus + Zimberelimab q21 for 3 cycles then radiological imaging and TURB will be repeated and patients with Stability of disease or down staging will continue Zimberelimab until disease progression, or unacceptable toxicities or completion of treatment (16 cycles). Patients with progressive disease after 3 cycles of study intervention will be treated as per clinical practice.
Study NCT05017233 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Spectral CT
Description: Using Spectral CT to scan Breast